Mexico’s health sector is undergoing a strategic shift that blends public procurement, industrial policy, and technolo...
Read story →
On June 10, 2026, Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) convened its annual meeting of stockholders through a recor...
Read story →
Pfizer Inc. reported a 1.6% drop in 2025 revenue to $62.6 billion, a sharp decline from the $100 billion peak reached in...
Read story →